Clinical Trial Update: Gingival Crevicular Fluid Levels of Sclerostin, Osteoprotegerin (OPG) and RANKL in Health, Disease and After Treatment [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 study evaluating gingival crevicular fluid levels of sclerostin, osteoprotegerin (OPG), and RANKL in healthy individuals, periodontitis patients, and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Periodontitis

Snippet

Sponsor: Umut BALLI | Conditions: Periodontitis | EARLY_Phase 1 | Status: COMPLETED